Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy
Journal of Cancer Research and Clinical Oncology · 2023
DOI: 10.1007/s00432-022-04565-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2023. Verfasst von Mümtaz Köksal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany. muemtaz.koeksal@ukbonn.de. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Hematologic Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Bonn.
Abstract (Originalsprache)
Background
Total body irradiation (TBI) is often a component of the conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematological malignancies. However, total marrow irradiation (TMI) could be an alternative method for reducing radiation therapy-associated toxicity, as it specifically targets the skeleton and thus could better protect organs at risk. Here, we compared dosimetric changes in irradiation received by the target volume and organs at risk between TBI and TMI plans. Materials and methods Theoretical TMI plans were calculated for 35 patients with various hematological malignancies who had already received TBI in our clinic. We then statistically compared irradiation doses between the new TMI plans and existing TBI plans. We examined whether TMI provides greater protection of organs at risk while maintaining the prescribed dose in the targeted skeletal area. We also compared beam-on times between TBI and TMI.
Results
TMI planning achieved significant reductions in the mean, minimum, and maximum irradiation doses in the lungs, kidneys, liver, spleen, and body (i.e., remaining tissue except organs and skeleton). In particular, the mean dose was reduced by 49% in the liver and spleen and by 55–59% in the kidneys. Moreover, TMI planning reduced the corpus beam-on time by an average of 217 s.
Conclusion
TMI planning achieved significant dose reduction in organs at risk while still achieving the prescribed dose in the target volume. Additionally, TMI planning reduced the beam-on time for corpus plans despite a high modulation factor. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany. muemtaz.koeksal@ukbonn.de.
- Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
- Department of Internal Medicine-Oncology/ Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.
- Deprtment of Radiation Oncology, Sana Hospital Offenbach, Offenbach, Germany.
- Department of Radiology, University Hospital Bonn, Bonn, Germany.
Förderung
- Universitätsklinikum Bonn
Zitieren
APA
Köksal, M., Kersting, L., Schoroth, F., Garbe, S., Koch, D., Scafa, D., Sarria, G. R., Leitzen, C., Heine, A., Holderried, T., Brossart, P., Zoga, E., Attenberger, U., & Schmeel, L. C. (2023). Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-022-04565-2
Vancouver
Köksal M, Kersting L, Schoroth F, Garbe S, Koch D, Scafa D, et al. Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy. Journal of Cancer Research and Clinical Oncology. 2023. doi:10.1007/s00432-022-04565-2
BibTeX
@article{Kksal2023,
author = {Köksal, Mümtaz and Kersting, Laura and Schoroth, Felix and Garbe, Stephan and Koch, David and Scafa, Davide and Sarria, Gustavo R and Leitzen, Christina and Heine, Annkristin and Holderried, Tobias and Brossart, Peter and Zoga, Eleni and Attenberger, Ulrike and Schmeel, Leonard C},
title = {Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2023},
doi = {10.1007/s00432-022-04565-2}
}
EUVIMED